Hansa Biopharma | Sustainability Performance
Hansa Biopharma AB specializes in developing enzyme-based therapeutics, focusing on treatments for rare immunological diseases and utilizing advanced biotechnology for product development.
2001
Sweden
51 - 200 employees
Biotechnology
$10M - 25M in revenue
Not profitable
Sustainability Ranking & Industry Benchmark
#2293
Overall#139
in Sweden#35
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Environmental
Digital emissionsEnergy consumptionGovernance
Targets
Renewable energy
Aligned
Renewable electricity
Reveal data for 1 credit
100%2023
Industry rank: 6 out of 251
Total electricity consumption
and % renewables
(MWh, % of consumption)
Industry rank: 6 out of 251
Total electricity
Share of renewable electricity
Industry benchmark
Digital Emissions
CO2e per visit (g)
Industry benchmark
B/M 0.26 g
B
Environmental ScoreScore B
Green HostingYes
Controversy level
- Hansa Biopharma's executive compensation was debated relative to its pre-profitability status.
Sustainability targets and commitments
| Target | Year | Value | Scope | Baseline |
|---|
